This coincides with our data, where using pharmaceutical inhibitors, we show that activation of p38 and JNK pathways, but not of ERK, is necessary and sufficient to phosphorylate PPARγ and cause subsequent apoptosis in the breast cancer cell lines studied. The gene discussed is PPARG; the disease is breast cancer.